Parsippany, NJ —In order to keep up with customer demand and production needs, Qosina, a global supplier of single-use medical devices, recently selected Evonik’s CYROLITE® G-20 HIFLO acrylic-based copolymer compound to manufacture their own specialized luer lock connector. CYROLITE® G-20 HIFLO is one of the world’s most advanced medical acrylics and is primarily used for the production of disposable medical devices
“Delays in manufacturing were creating issues for us in terms of meeting customer demand in a timely fashion,” said Geri Trautman, Product Development Manager at Qosina. “So, after we started working on our own tooling and molding source, Evonik pointed us toward their CYROLITE® G-20 HIFLO, a material that is easy to process and saves us considerable production costs over the long run.”
A BPA-free, impact-modified copolymer ideal for the injection molding and extrusion of medical devices, CYROLITE® G-20 HIFLO offers a balance of physical properties and chemical resistance, excellent processability, and flow characteristics paramount for extremely thin-walled applications and complex multi-cavity molds. CYROLITE® can also be bonded to PVC tubing and sterilized by EtO gas and gamma irradiation.
CYROLITE® G-20 HIFLO ultimately lowered the cost of production due to reduced required mold temperatures, ease in processability, and faster cycle times.
“When customers come to us for material recommendation, collaboration is important to ensure that all stakeholders share the application requirements and material knowledge,” said Maurice Biagini, Commercial Director at Evonik. “In this case, CYROLITE® G-20 HIFLO was the perfect choice for the application because it has the right balance of physical properties and excellent processability.”
“This efficiency in the production process, coupled with proven performance capabilities, made this a win-win across the board for us,” said Michael Gillis, Supplier Relations Manager at Qosina. “We were able to make more parts in less time, enjoy less downtime on the molding machine, and also take advantage of energy cost savings due to increased productivity.”
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess, and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.
The Performance Materials Segment is managed by Evonik Performance Materials GmbH. This segment focuses its global activities on developing and manufacturing polymer materials and intermediates, especially for use in agriculture and in the rubber and plastics industry. In 2017, the segment’s roughly 4,400 employees generated sales about €3.8 billion. For more information on CYROLITE® acrylic-based copolymer compounds visit cyrolite.com.
Qosina was established in 1980 to serve medical device companies by providing stock components. Companies purchase from Qosina to eliminate the cost of tooling their own components and to receive immediate delivery from inventory. This particular approach is useful to companies of all sizes, but has proven especially effective for small to mid-range manufacturing companies. Qosina supports customer production requirements with timely delivery from their ISO 9001, ISO 13485, and ISO 14001 certified 95,000 sq. ft. climate-controlled facility that includes a Class 8 Clean Room. For more information, visit qosina.com.